Determinants of antipsychotic medication use among older people living in aged care homes in Australia

International Journal of Geriatric Psychiatry

Volumn 25, Issue 5, 2010, Pages 449-457

  Nishtala, Prasad S ^a   McLachlan, Andrew J ^a,b   Bell, J Simon ^a,c   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antipsychotic agents; Drug utilization; Older people; Pharmaceutical services; Pharmacists

Indexed keywords

NEUROLEPTIC AGENT;

AGED; AGGRESSION; AGING; AGITATION; ARTICLE; AUSTRALIA; BEHAVIOR DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DEMENTIA; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG MONITORING; FEMALE; GROUPS BY AGE; HOME FOR THE AGED; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOOD DISORDER; PARANOIA; PREDICTOR VARIABLE; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; AUSTRALIA; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; HOMES FOR THE AGED; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; NURSING HOMES; ODDS RATIO; RETROSPECTIVE STUDIES;

EID: 77950804431     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2359     Document Type: Article

References (33)

1. Pharmaceutical Society of Australia. Guidelines and Standards for the Collaborative and Pharmacist Residential Medication Management Review (RMMR) Program and Quality Use of Medicines (QUM). Available at: http://www.psa.org.au/ site.php?id=1122 (Accessed on 8 December 2008).
2. AIHW. 2007. Residential Aged Care in Australia 2006-07: A Statistical Overview (Available at URL: http://www.aihw.gov.au/publications/index.cfm/title/ 10589 (Accessed on 1 December 2008).
3. Alanen HM, Finne-Soveri H, Noro A, Leinonen E. 2008. Use of antipsychotics in older home care patients in Finland. Drugs Aging 25: 335-342. (Pubitemid 351440451)
4. Aupperle P. 2006. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics. Am J Alzheimers Dis Other Demen 21: 101-108.
5. Ayalon L, Gum AM, Feliciano L, Arean PA. 2006. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 166: 2182-2188. (Pubitemid 44748764)
6. Ballard C, Hanney ML, Theodoulou M, et al. 2009. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 8: 151-157.
7. Ballard C, Waite J. 2006. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev (1) CD003476.
8. Chung JA, Cummings JL. 2000. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment. Neurol Clin 18: 829-846. (Pubitemid 32042598)
9. Finkel S. 2000. Introduction to behavioural and psychological symptoms of dementia (BPSD). Int J Geriatr Psychiatry 15 (Suppl 1): S2-4.
10. Formiga F, Fort I, Perez-Castejon JM, et al. 2005. Association between risperidone treatment and cerebrovascular adverse events in elderly patients with dementia. J Am Geriatr Soc 53: 1446-1448. (Pubitemid 41602503)
11. Gill SS, Bronskill SE, Normand SL, et al. 2007. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146: 775-786. (Pubitemid 351650498)
12. Gill SS, Rochon PA, Herrmann N, et al. 2005. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 330: 445. (Pubitemid 40314208)
13. Giron MS, Forsell Y, Bernsten C, et al. 2001. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 16: 900-906. (Pubitemid 32926775)
14. Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. 2003. Use of psychotropics among home-dwelling nondemented and demented elderly. Int J Geriatr Psychiatry 18: 1135-1141. (Pubitemid 38049247)
15. Heeren O, Borin L, Raskin A, et al. 2003. Association of depression with agitation in elderly nursing home residents. J Geriatr Psychiatry Neurol 16: 4-7. (Pubitemid 37408282)
16. Hosia-Randell H, Pitkälä K. 2005. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22: 793-800.
17. Jeste DV, Lacro JP, Bailey A, et al. 1999. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 47: 716-719. (Pubitemid 29266640)
18. Katz I, de Deyn PP, Mintzer J, et al. 2007. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry 22: 475-484. (Pubitemid 46831692)
19. Liperoti R, Gambassi G, Lapane KL, et al. 2005. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry 66: 1090-1096. (Pubitemid 41442273)
20. Menon AS, Gruber-Baldini AL, Hebel JR, et al. 2001. Relationship between aggressive behaviors and depression among nursing home residents with dementia. Int J Geriatr Psychiatry 16: 139-146. (Pubitemid 32166304)
21. Paleacu D, Barak Y, Mirecky I, Mazeh D. 2008. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. Int J Geriatr Psychiatry 23: 393-400. (Pubitemid 351566336)
22. Parmelee PA, Katz IR, Lawton MP. 1989. Depression among institutionalized aged: assessment and prevalence estimation. J Gerontol 44: M22-29. (Pubitemid 19038735)
23. Pollock BG, Mulsant BH, Rosen J, et al. 2007. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry 15: 942-952.
24. Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH. 2007. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 15: 416-424.
25. Rochon PA, Stukel TA, Bronskill SE, et al. 2007. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 167: 676-683.
26. Rochon PA, Stukel TA, Sykora K, et al. 2005. Atypical antipsychotics and parkinsonism. Arch Intern Med 165: 1882-1888. (Pubitemid 41352083)
27. Schneider LS, Dagerman KS, Insel P. 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934-1943. (Pubitemid 41464695)
28. Schneider LS, Tariot PN, Dagerman KS, et al. 2006. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 355: 1525-1538. (Pubitemid 44547805)
29. Setoguchi S, Wang PS, Alan Brookhart M, et al. 2008. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc 56: 1644-1650.
30. Snowdon J, Day S, Baker W. 2005. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 20: 1146-1152. (Pubitemid 43040681)
31. Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E. 2008. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf 31: 7-20.
32. van Iersel MB, Zuidema SU, Koopmans RT, Verhey FR, Olde Rikkert MG. 2005. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events. Drugs Aging 22: 845-858.
33. Woods SW. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64: 663-667.